Enzyme-Triggered Antineoplastic Hydrogels via Self-Assembly
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional drug delivery systems using polymer matrices often cause side effects due to matrix degradation, and existing precursors for enzyme-triggered hydrogel formation have limited biological activities.
Innovation Solution
The development of molecular nanofibers through enzyme-triggered self-assembly of small molecules, which form their own gel without the need for a polymer matrix, allowing for self-delivery of pharmaceutical agents like paclitaxel, doxorubicin, and other antineoplastic agents, enabling controlled release and enhanced biological activity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional polymer matrices are used for drug delivery, then structural support and drug encapsulation are provided, but side effects occur due to matrix degradation
Solution Approach 1:
The invention extracts and eliminates the polymer matrix component from conventional drug delivery systems. By using small molecule hydrogelators that self-assemble into nanofibers, the system removes the degradable polymer matrix that causes harmful side effects, while retaining the essential functions of structural support and drug encapsulation through the self-assembled nanofiber network.
Solution Approach 2:
The invention changes the fundamental parameter of the delivery system from polymer-based macrostructures to small molecule-based nanofiber structures. This parameter change transforms the system from one that degrades into harmful byproducts to one that uses biocompatible small molecules that self-assemble and can be metabolized more safely.
2Ease of manufacture
If existing precursors are used for enzyme-triggered hydrogel formation, then hydrogelation can be initiated, but the precursors have limited biological activities
Solution Approach 1:
The invention designs small molecule precursors that serve multiple functions: they can be enzymatically converted to form hydrogels, they inherently possess antineoplastic biological activities, and they can encapsulate additional drug payloads. This multi-functionality eliminates the need for separate inactive precursors and actively contributes to therapeutic efficacy.
Solution Approach 2:
The invention merges the hydrogel-forming precursor function with antineoplastic drug activity into a single molecular entity. The small molecule precursors contain both the hydrogelator moieties that enable self-assembly and the bioactive moieties that provide cancer-killing activity, combining structure formation and therapeutic function in one component.
3Productivity
If hydrophobic drugs like paclitaxel are delivered using conventional systems, then drug delivery is achieved, but solubility and stability issues persist
Solution Approach 1:
The self-assembled nanofiber network creates a porous, three-dimensional structure with high surface area and interconnected channels. This porous architecture provides extensive interfaces for hydrophobic drug interaction and stabilization, allowing paclitaxel to be solubilized and stabilized within the nanofiber matrix through hydrophobic interactions and physical entrapment.
Solution Approach 2:
The invention creates a composite system where hydrophobic drug molecules are integrated within the hydrophilic nanofiber network. This composite structure combines the properties of both components: the hydrophobic drug provides therapeutic activity while the hydrophilic nanofiber matrix provides solubility enhancement and stability, enabling effective delivery of hydrophobic agents.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach allows for the effective delivery of hydrophobic drugs like paclitaxel with improved solubility and stability, maintaining their activity while avoiding matrix-related side effects, and provides a method for sustained release and controlled delivery of antineoplastic agents.
Implementation Method 1
the enzyme-triggered formation of molecular nanofibers can inhibit bacteria growth or selectively kill cancer cells in vitro
Implementation Method 2
supramolecular hydrogels, whose networks consist of nanofibers formed through self-assembly of small molecules
Data Source
AI summary
Disclosed is a general methodology to create nanofibers of therapeutic molecules that have a dual role, as both the delivery vehicle and the drug itself. It is shown that with proper molecular design, the integration of enzymatic reaction and self-assembly provides a powerful method to create molecular hydrogels of clinically-used therapeutics without compromising their bioactivities. In addition, the results disclosed herein demonstrate enzyme-instructed self-assembly as a facile strategy for generating the supramolecular hydrogels of molecules that inherently have poor solubility in water. For example, by covalently connecting paclitaxel with a motif that is prone to self-assemble, a hydrogel of paclitaxel can be formed without compromising the activity of the paclitaxel.